Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Apr 21;300(6731):1025–1026. doi: 10.1136/bmj.300.6731.1025

Kawasaki syndrome: lessons for Britain.

J G Bissenden 1, S Hall 1
PMCID: PMC1662747  PMID: 2188694

Full text

PDF
1025

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiba T., Sato T., Yoshikawa M., Otaki S., Kobayashi Y., Nakasato M., Suzuki H., Hayashi T. Prognostic significance of the size of coronary artery aneurysms in Kawasaki disease. Acta Paediatr Jpn. 1989 Feb;31(1):7–11. doi: 10.1111/j.1442-200x.1989.tb01262.x. [DOI] [PubMed] [Google Scholar]
  2. Cullen S., Ward O. C., Denham B. Bacterial endocarditis and lymphadenopathy mimicking Kawasaki disease. Ir Med J. 1989 Feb;82(1):32–33. [PubMed] [Google Scholar]
  3. Friesen C. A., Gamis A. S., Riddell L. D., Roberts C. C., Jackson M. A. Bilirubinuria: an early indicator of gallbladder hydrops associated with Kawasaki disease. J Pediatr Gastroenterol Nutr. 1989 Apr;8(3):384–386. [PubMed] [Google Scholar]
  4. Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., Hayashidera T., Tamura T., Hirose O., Manabe Y., Yokoyama T. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984 Nov 10;2(8411):1055–1058. doi: 10.1016/s0140-6736(84)91504-6. [DOI] [PubMed] [Google Scholar]
  5. Hall S. M., Glickman M. The British Paediatric Surveillance Unit. Arch Dis Child. 1988 Mar;63(3):344–346. doi: 10.1136/adc.63.3.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ichida F., Fatica N. S., Engle M. A., O'Loughlin J. E., Klein A. A., Snyder M. S., Ehlers K. H., Levin A. R. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin. Pediatrics. 1987 Dec;80(6):828–835. [PubMed] [Google Scholar]
  7. Kato H., Ichinose E., Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr. 1986 Jun;108(6):923–927. doi: 10.1016/s0022-3476(86)80928-3. [DOI] [PubMed] [Google Scholar]
  8. Leung D. Y., Cotran R. S., Kurt-Jones E., Burns J. C., Newburger J. W., Pober J. S. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet. 1989 Dec 2;2(8675):1298–1302. doi: 10.1016/s0140-6736(89)91910-7. [DOI] [PubMed] [Google Scholar]
  9. Management of Kawasaki syndrome: a consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988. Pediatr Infect Dis J. 1989 Oct;8(10):663–667. [PubMed] [Google Scholar]
  10. Mason W. H., Jordan S. C., Sakai R., Takahashi M., Bernstein B. Circulating immune complexes in Kawasaki syndrome. Pediatr Infect Dis. 1985 Jan-Feb;4(1):48–51. doi: 10.1097/00006454-198501000-00012. [DOI] [PubMed] [Google Scholar]
  11. Maury C. P., Salo E., Pelkonen P. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med. 1989 May;113(5):651–654. [PubMed] [Google Scholar]
  12. Melish M. E., Marchette N. J., Kaplan J. C., Kihara S., Ching D., Ho D. D. Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome. Nature. 1989 Jan 19;337(6204):288–290. doi: 10.1038/337288a0. [DOI] [PubMed] [Google Scholar]
  13. Murai T., Kuroda N., Shinozuka T., Kurihara K., Yanagida J., Watanabe H., Saito K., Maurai N., Imai M. Coronary aneurysms in a young adult: report of a case suspected of Kawasaki disease. Med Sci Law. 1989 Jan;29(1):59–63. doi: 10.1177/002580248902900109. [DOI] [PubMed] [Google Scholar]
  14. Newburger J. W., Burns J. C. Kawasaki syndrome. Cardiol Clin. 1989 May;7(2):453–465. [PubMed] [Google Scholar]
  15. Newburger J. W., Takahashi M., Burns J. C., Beiser A. S., Chung K. J., Duffy C. E., Glode M. P., Mason W. H., Reddy V., Sanders S. P. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986 Aug 7;315(6):341–347. doi: 10.1056/NEJM198608073150601. [DOI] [PubMed] [Google Scholar]
  16. Rauch A. M. Kawasaki syndrome: issues in etiology and treatment. Adv Pediatr Infect Dis. 1989;4:163–182. [PubMed] [Google Scholar]
  17. Shulman S. T., Rowley A. H. Does Kawasaki disease have a retroviral aetiology? Lancet. 1986 Sep 6;2(8506):545–546. doi: 10.1016/s0140-6736(86)90115-7. [DOI] [PubMed] [Google Scholar]
  18. Smith L. B., Newburger J. W., Burns J. C. Kawasaki syndrome and the eye. Pediatr Infect Dis J. 1989 Feb;8(2):116–118. [PubMed] [Google Scholar]
  19. Ueno Y., Takano N., Kanegane H., Yokoi T., Yachie A., Miyawaki T., Taniguchi N. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol. 1989 Jun;76(3):337–342. [PMC free article] [PubMed] [Google Scholar]
  20. Westphalen M. A., McGrath M. A., Kelly W., Moore F. J., Ziegler J. B. Kawasaki disease with severe peripheral ischemia: treatment with prostaglandin E1 infusion. J Pediatr. 1988 Mar;112(3):431–433. doi: 10.1016/s0022-3476(88)80329-9. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES